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Bayesian random threshold estimation in
a Cox proportional hazards cure model
Lili Zhao,a*† Dai Feng,b Emily L. Bellilec and
Jeremy M. G. Taylora
In this paper, we develop a Bayesian approach to estimate a Cox proportional hazards model that allows a
threshold in the regression coefficient, when some fraction of subjects are not susceptible to the event of interest.
A data augmentation scheme with latent binary cure indicators is adopted to simplify the Markov chain Monte
Carlo implementation. Given the binary cure indicators, the Cox cure model reduces to a standard Cox model
and a logistic regression model. Furthermore, the threshold detection problem reverts to a threshold problem
in a regular Cox model. The baseline cumulative hazard for the Cox model is formulated non-parametrically
using counting processes with a gamma process prior. Simulation studies demonstrate that the method provides
accurate point and interval estimates. Application to a data set of oropharynx cancer patients suggests a signif-
icant threshold in age at diagnosis such that the effect of gender on disease-specific survival changes after the
threshold. Copyright © 2013 John Wiley & Sons, Ltd.
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1. Introduction
This paper is motivated by a data set of patients with oropharynx cancer. The clinicians suspect that
gender is a prognostic factor for disease-specific survival. However, the Kaplan–Meier (K-M) curves of
women and men overlap at early times and cross during the follow-up, which suggests no difference in
survival between men and women. But for a cohort of young patients, men tend to have worse survival
than women. This seems to indicate a potential threshold in the age of diagnosis such that the gender
effect is different below this threshold than above it. Further inspection of the data reveals that the K-M
survival curve levels off to about 0.7. The stable plateau at the tail may be taken as empirical evidence of
a cured fraction. The use of standard survival analysis for detection of the threshold may be inappropriate
as not all patients will die of oropharynx cancer. To this end, we propose a survival model that allows for
a threshold in the age of diagnosis to investigate a potential interaction between age and gender when a
fraction of patients are cured.
Motivated by the oropharynx cancer data set, but not limited to it, this model has a broad application
in biomedical studies. For example, physicians will rely on a threshold in a biomarker or combination
of biomarker signatures to guide the choice of therapy for an individual patient. The therapy targeting a
specific biomarker generally will work effectively for patients when that biomarker is highly expressed,
and thus, it is convenient to find a threshold in the biomarker such that therapy should only be given to
those patients with the biomarker levels exceeding the threshold. In general, better characterizing can-
cers at the molecular level will lead to more efficient treatment, and methodology to improve estimates
of a threshold point will help this characterization.
Several authors considered a Cox model with an unknown threshold in the covariate. Liang et al. [1]
and Pons [2] proposed approaches that can be used to study the model as described in the motivating
example if no cure fraction is present in the data, where the influence of a covariate ´1 (e.g., gender)
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jumps at a certain threshold of ´2 (e.g., age). Luo and Boyett [3] studied a model where a constant
is added to the regression on a covariate ´1 after a threshold in ´2. In this model, the baseline haz-
ard changes after the threshold. Jensen and Lutkebohmert [4] and Kosorok and Song [5] considered
a Cox-type regression model with a piecewise linear functional form of the covariates. However, the
aforementioned models are not appropriate when a cured fraction is present in the population.
Othus et al. [6] estimated a threshold in a covariate in the cure model setting. They assume that there
is a threshold in a covariate ´2, where a sudden jump or fall occurs in the hazard value or cure probabil-
ity. But their model is restricted to a simple binomial–exponential mixture model, in which a binomial
model is used to estimate the cure rate and exponential distribution is used for the conditional survival.
In this paper, we extend the threshold detection problem to a more general cure model in which a logistic
regression is used to evaluate the effect of covariates on the cure rate and a standard proportional hazard
model is used for the conditional survival. This mixture cure model (without threshold detection) has
been studied by many authors [7–9], and they use expectation maximization type algorithms to compute
the maximum likelihood estimates. We build on this previous research to implement a Bayesian esti-
mation method for the Cox proportional hazards cure model and extend it to allow a threshold in the
regression coefficients. We will show that applying Bayesian methods in the mixture cure rate model
is straightforward. Using a data augmentation scheme, the latent cure indicators are updated. As we
demonstrate later, conditional on these indicators, the cure model reduces to a standard Cox model and a
standard logistic regression model. Furthermore, our ultimate goal of detecting a threshold is simplified
to a threshold problem in the regular Cox or logistic regression model.
The rest of the article is organized as follows: Section 2 outlines the model; Section 3 presents the
Bayesian estimation and evaluation of model fit; Section 4 provides simulation studies; the analysis of
the oropharynx cancer data is presented in Section 5; the paper ends with a discussion in Section 6.
2. Model description
The survival time, T , is assumed to be T D vT  C .1  v/1, where v is an indicator of whether
a subject will eventually (v D 1) or never (v D 0) experience the event, and T  denotes the fail-
ure time if the subject is not cured. S.t jv D 1/ is the conditional survival function for patients
who will experience the event, often called the latency distribution. The marginal survival function is
S.t/ D c C .1  c/S.t jv D 1/, where c D P.v D 0/.
We consider a Cox proportional hazard model in the latency part of the cure model. Similar to Liang
et al. [1] and Pons [2], a threshold,  , could be present in a time-independent covariate ´2, and the effect
of ´1 changes after  , specifically,
ƒ.t j´0; ´1; ´2;  I v D 1/ D ƒ0.t/ expfˇ0´0 C ˇ1´1I.´2 6 / C ˇ2´1I.´2 > /g (1)
where I.´2 6 / is a generic indicator function, which takes value of 1 if ´2 6  . ˇ1 repre-
sents the effect of ´1 for ´2 6  , and ˇ2 represents the effect of ´1 for ´2 >  . ´0 is a vector
of baseline covariates. Let ˇ D .ˇ0; ˇ1; ˇ2/ and Q´./ D .´0; ´1I.´2 6 /; ´1I.´2 > //, and ´0
could include ´2 but is distinct from ´1. ƒ0.t/ is an unspecified cumulative baseline hazard function.
S.t j Q´./; v D 1/ D expfƒ.t j Q´./; v D 1/g.
A cure fraction c is modeled by a logistic regression or a probit model. In logistic regression,
c.x/ D P.v D 0jx/ D exp.x/
1Cexp.x/ , and the vector of covariates x includes the intercept. In a probit model,
c.x/ D ˆ.x/, and ˆ is the CDF of a standard normal distribution. These models can be extended to
include a threshold in a covariate similar to that in the latency model.
3. Bayesian estimation and model selection
In practice, we observe .ti ; ıi ; xi ; ´i /, and i D 1;    ; n, where ti , denotes the observed survival time for
the i th patient, ıi is 0 if ti is censored and 1 otherwise, and ´i D .´0i ; ´1i ; ´2i / is a vector of covariates
that may associate with the risk of experiencing the event, and xi is a vector of covariates associated
with the chance of cure. xi and ´i could be identical.
Copyright © 2013 John Wiley & Sons, Ltd. Statist. Med. 2014, 33 650–661
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It follows that vi D 1 if ıi D 1, but if ıi D 0, vi is unknown, and it can be 1 or 0. The probability that
a censored patient will eventually experience the event is given by
pvi D P.vi D 1jxi ; ´i ; T > ti / D
.1  c.xi //S.ti j´i ; vi D 1/
.1  c.xi //S.ti j´i ; vi D 1/ C c.xi / (2)
In Bayesian sampling, a data augmentation algorithm, described by Smith and Roberts [10] and
Diebolt and Roberts [11], arises naturally for estimating the missing data, which in this case is an indi-
cator of whether the patient is cured or uncured. A vector of v D .v1;    ; vn/ is introduced as a vector
of latent Bernoulli random variables. For patient i with ıi D 0, vi  Bernoulli.pvi /. Conditional on
the vector of .v1;    ; vn/, the model reduces to the standard Cox model for patients with vi D 1. In
the incidence part, the model reduces to the standard logistic regression model, in which the vector of
.v1;    ; vn/ is regressed on covariates .x1;    ; xn/.
3.1. Bayesian inference
We formulate the standard Cox model using counting processes [12]. Let Ni .t/ be the number of events
that occurred up to time t . Let i .t/ be the intensity function of Ni .t/, that is, E.dNi .t/jFt / D
i .t/dt , where dNi .t/ is the increment of Ni over the small time interval Œt; t C dt/. If subject
i experiences the event during this interval, dNi .t/ will take the value 1; otherwise, dNi .t/ is 0.
Ft represents the available data just before time t . Then the proportional hazards model takes the
form i .t/ D Yi .t/0.t/ expfˇ Q´i ./g, where Yi .t/ is 1 if subject i is under observation at time t
and 0 otherwise.
The counting process increments dNi .t/ in the time interval Œt; t C dt/ are assumed to be indepen-
dent Poisson random variables with means i .t/dt D Yi .t/ expfˇ Q´i ./gdƒ0.t/, where dƒ0.t/ is the
increment in the cumulative baseline hazard function during the time interval Œt; t C dt/. Given v, the
formulation for the latency applies only to patients with vi D 1.
The time intervals are constructed based on the ordered distinct event times, fsj I j D 1;    ; J g, where
J is the total number of distinct times, sJ is the maximum observed event time, and sJC1 is infinity. The
observed data D are assumed to be available within these intervals, such that D D fRj ;Dj ; ´i ; j D
1;    ; J I i D 1;    ; ng, where Rj is the risk set and Dj is the event set in interval Œsj ; sjC1/. Let
 D .ˇ; dƒ0.j /; j D 1;    ; J /, and the likelihood function for the aforementioned model is
L.;  I v D 1/ D
JY
jD1
Gj
where
Gj D exp
8<
:
X
i2Rj
dƒ0.j / expfˇ Q´i ./g
9=
;
Y
i2Dj
dƒ0.j / expfˇ Q´i ./g (3)
The gamma process is used as a prior for the cumulative baseline hazard function ƒ0 [13]. That is,
ƒ0  GP.c0ƒ0; c0/; where ƒ0 is often assumed to be a known parametric function. For example,
ƒ0 D yk0 corresponds to the Weibull distribution, and c0 represents the degree of confidence in this
prior guess. The prior distribution for ˇ  MVN.0; †0/, where 0 and †0 are pre-specified.
In this study,  is a parameter to be estimated from the data. Let ´2.1/ < ´2.2/ <    ; < ´2.K1/ be
distinct ordered values of ´2i ; i D 1;    ; n, and ´2.K/ is the largest value of ´2. We propose to sam-
ple  in two steps. The first step follows the work of Carlin et al. [14] and Lange et al. [15], in which
the threshold is treated as a discrete variable in an application to simple regression models and Poisson
processes. We first sample  from a categorical distribution taking the value ´2.k/ with probability k;
that is,
  Multinomial.1; .1;    ; k;    ; K1// (4)
k D
L

; ´2.k/ I v D 1

PK1
kD1 L

; ´2.k/ I v D 1
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Given the intervals, the distribution of  is assumed to be continuous with a uniform distribution,
´2.1/ <  < ´2.K/ . Thus, having obtained a draw of ´2.k/ in step 1, we will sample  from Uniform
Œ´2.k/ ; ´2.kC1/  in the second step, which will result in a continuous posterior distribution of  .
As an alternative to the aforementioned Gibbs sampling approach, we can directly consider  as a
continuous variable, and the conditional posterior density of  can be written as
 /
JY
jD1
Gj I.min.´2/ <  < max.´2//
We use the adaptive Metropolis algorithm [16] to sample  . Specifically, we consider the proposal
distribution given at iteration l by
Q.l/.; :/ D .1  B/N

; 2:382	 .l/

C BN.; 0:12/
where  is a candidate value for  simulated from proposal Q.l/.; :/. 	 .l/ is the empirical estimate
of the variance of the target distribution based on the entire history up to l th iteration. As suggested in
Roberts and Rosenthal [16], we take B to be 0.05.
When no threshold is present in the model,  is not identifiable [17]. It is possible to estimate the
existence of a threshold in a mixture model as described by Skates et al. [18], in which reversible jump
Markov chain Monte Carlo (MCMC) was used to move between a linear model with no threshold and
a model with a threshold. But in our more complicated setting of a Cox model with a cured fraction,
we have considered two other strategies to evaluate the presence of a threshold. First, we use model
selection criteria to compare the models with and without a threshold. Second, we constrain  in the
range (min.´2/; max.´2/), and let the non-identifiability be reflected in the posterior distribution of 
and ˇ2  ˇ1. Our goal is to identify a sharp estimate of  when the data clearly indicate a threshold.
When the data do not clearly indicate a threshold, estimates of  would have large uncertainty, and the
contrast parameter of ˇ2  ˇ1 would be close to 0.
We can thus carry out the following hybrid Gibbs sampling scheme:
1. Sample vi  Bernouli.pvi / for patients with ı D 0, where pvi is defined as in (2).
Steps 2–4 are applied for patients with vi D 1.
2. Sample from
P.ˇj;ƒ0;D/ /
JY
jD1
Gj exp

1
2
.ˇ  0/†10 .ˇ  0/

using random-walk Metropolis algorithm as developed by Haario et al. [19].
3. Sample ƒ0.j /; j D 1;    ; J as
dƒ0.j /  G
0
@c0.sjC1  sj / C dj ; c0 C X
i2Rj
expfˇ Q´ i ./g
1
A
where dj is the number of events in Œsj ; sjC1/.
4. Sample  as defined in (4), or sample  using the adaptive Metropolis algorithm as developed by
Roberts and Rosenthal [16].
5. Sample  using random-walk Metropolis algorithm [19] in the logistic regression model. For a
probit model, the truncated normal sampling approach proposed by Albert and Chib [20] can be
used. A multivariate normal prior was used for  .
6. Update S.ti j Q´ i ./; vi D 1/ D exp
n
PJjD1 Yi .sj /dƒ0.j / expfˇ Q´ i ./go and c.xi / D ci D
exp.xi /
1Cexp.xi / , and update pvi as a function of c.xi / and S.ti j Q´ i ./; vi D 1/. If there is no covari-
ate in the incidence model, we can estimate the cure rate c by a logistic regression model with just
an intercept or simply averaging over the indicator variables v1;    ; vn.
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3.2. Model selection
We computed two Bayesian model comparison criterions for selecting the best model. To alleviate the
concern that the standard deviance information criterion (DIC) measure [21] does not properly reflect the
correct effective number of parameters in mixture models, Celeux [22] recommended a modified DIC,
termed DIC3, which estimates D.EŒjy/ using the posterior mean of the observed likelihood averaged
across the cured and uncured subjects. Specifically,
DIC3 D  4
m
mX
lD1
(
nX
iD1
log f .l/.yi /
)
C 2
nX
iD1
log
(
1
m
mX
lD1
f .l/.yi /
)
f .l/.yi / is approximated by8<
:

1  c.l/i
 JX
jD1
dNi .sj /dƒ
.l/
0 .j / exp
n
ˇ.l/ Q´i . .l//
o
S .l/.ti j Q´ i ./; vi D 1/
9=
;
ıi

n
c
.l/
i C

1  c.l/i

S .l/.ti j Q´ i ./; vi D 1/
o1ıi
where m is the number of draws of the posterior distribution. c.l/i D exp.
.l/xi /
1Cexp..l/xi / , dƒ
.l/
0 .j /, ˇ
.l/
, and
S .l/.ti j Q´ i ./; vi D 1/ are the values of the parameters for the l th draw.
The log-pseudo-marginal likelihood (LPML) [23] is a cross-validated leave-one-out measure of a
model’s ability to predict the data. It is valid for small and large samples and does not suffer from a
heuristic justification based on large sample normality. LPML is defined based on the conditional pre-
dictive ordinate (CPO) statistic for the i th observation, and CPOi is given by CPOi D f .Di jD.i//,
where Di denote the i th observation, and D.i/ denote the data with i th observation deleted. The
log of the product of the CPO statistics under a given model is the LPML statistic for that model,
LPML D PniD1 log CPOi . The model with larger LPML is preferred. A Monte Carlo approximation of
CPOi is given by Chen et al. [24]: LPML D PniD1 log ˚ 1m PmlD1 1=f .l/.yi / :
4. Simulations
Simulation studies were conducted to evaluate the proposed approach. All simulations consist of 1000
experimental replications, each with sample size of n D 200 or n D 400. Survival times, T , are gener-
ated from a logistic–exponential mixture model, where c.´/ D .1 C exp.1  2´1  3´2//1, and
S.t jv D 1I ´/ D expf exp.ˇ0´2 Cˇ1´1I.´2 6 /Cˇ2´1I.´2 > //tg. In this formulation, the baseline
hazard function is constant with a rate of 1. ´1 and ´2 are fixed by design. ´1 D 0:5 for half of the
sample size and ´1 D 0:5 for the other half, and the covariate ´2 is generated from uniform [0, 10].
The  is assumed to be 3, 5, 7, or 15 in which no threshold is present. Each subject is followed up until
at most time D 5. Censoring times C are generated from an exponential distribution with censoring rate
of 4.5. The data for each observation are .t; ı; ´1; ´2/, where t D min.T; C; 5/. With the choices of the
parameters listed in Table I, the expected censoring proportion including those cured is around 0.54, and
the observed cure rate is around 0.43.
The models were implemented in R. A multivariate t -distribution with a degree of freedom of 3 was
used as the proposal density in the random-walk Metropolis algorithm in sampling ˇ and  . The pro-
posal density centered at the previous value, and the covariance was adaptive as developed by Haario
[19], which uses the empirical covariance from an extended burn-in period. We proposed two algorithms
to estimate the threshold. We found that the adaptive Metropolis algorithm in step 4 perform better than
the discrete algorithm. For the rest of this article, the adaptive Metropolis algorithm in step 4 is used.
Patients who survive after the last observed survival time are considered as cured in the estimation pro-
cedure. We observed that the chain mixes well. The priors are quite vague relative to the likelihood: a
vector of zeros is the prior mean of ˇ and  ; †0 is the prior covariance matrix with 100 on the diagonal
for ˇ and  . In the gamma process prior, ƒ0 is assumed to have an exponential distribution (k0 D 1)
with  D 0:1 and c0 D 0:1, namely dƒ0.j /  G.0:1  0:1.sjC1  sj /; 0:1/. The value of 0.1 for 
underestimates the true value of , but a small c0 of 0:1 gives large uncertainty about this .
With a burn-in of 5000 iterations, an additional 10,000 iterations were used for inference. Results
from Table I indicate that the proposed model accurately estimates the true values of all the parameters
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Table I. List of parameters used in simulation and performance statistics.
Mean (ESE)a SSEb MSE CPc Mean (ESE) SSE MSE CP
Parameter True n D 200 n D 400
 5 5.01 (0.98) 0.72 0.52 95 5.00 (0.39) 0.39 0.15 96
ˇ0 0.05 0.05 (0.04) 0.04 0.002 95 0.05 (0.03) 0.03 0.001 94
ˇ1 1 0.98 (0.50) 0.51 0.26 95 0.97 (0.29) 0.29 0.08 95
ˇ2 1 1.02 (0.40) 0.40 0.16 94 1.00 (0.24) 0.23 0.05 95
1 0.2 0.21 (0.35) 0.36 0.13 95 0.22 (0.24) 0.25 0.06 93
2 0.5 0.57 (0.35) 0.36 0.13 94 0.52 (0.24) 0.24 0.06 93
3 0.1 0.11 (0.06) 0.06 0.004 95 0.10 (0.04) 0.04 0.002 93
ˇ2  ˇ1 2 2.00 (0.64) 0.63 0.40 96 1.97 (0.37) 0.37 0.14 97
 7 6.65 (1.03) 0.80 0.77 96 6.96 (0.39) 0.37 0.14 95
ˇ0 0.05 0.05 (0.04) 0.04 0.002 95 0.05 (0.03) 0.03 0.002 95
ˇ1 1 1.00 (0.44) 0.44 0.19 96 0.97 (0.23) 0.24 0.06 94
ˇ2 1 0.98 (0.53) 0.60 0.36 94 1.01 (0.31) 0.31 0.10 95
1 0.2 0.21 (0.35) 0.36 0.13 95 0.22 (0.24) 0.25 0.06 93
2 0.5 0.58 (0.35) 0.36 0.14 94 0.53 (0.24) 0.24 0.06 94
3 0.1 0.11 (0.06) 0.06 0.004 95 0.10 (0.04) 0.04 0.001 94
ˇ2  ˇ1 2 1.98 (0.70) 0.75 0.57 96 1.98 (0.38) 0.39 0.15 96
 3 3.56 (1.33) 1.00 1.32 96 3.15 (0.58) 0.59 0.37 95
ˇ0 0.05 0.05 (0.04) 0.04 0.002 96 0.05 (0.03) 0.03 0.001 94
ˇ1 1 0.89 (0.75) 0.84 0.71 93 0.93 (0.41) 0.41 0.17 94
ˇ2 1 1.03 (0.41) 0.43 0.19 96 0.99 (0.22) 0.25 0.06 95
1 0.2 0.20 (0.35) 0.35 0.12 95 0.21 (0.24) 0.25 0.06 93
2 0.5 0.55 (0.36) 0.37 0.14 94 0.50 (0.24) 0.24 0.06 94
3 0.1 0.10 (0.06) 0.06 0.004 95 0.10 (0.04) 0.04 0.00 93
ˇ2  ˇ1 2 1.91 (0.86) 0.94 0.89 97 1.93 (0.46) 0.49 0.25 95
 No 4.89 (2.81) 1.36 — — 4.89 (2.86) 1.40 — —
ˇ0 0.05 0.05 (0.04) 0.04 0.002 95 0.05 (0.03) 0.03 0.001 94
ˇ1 1 0.97 (1.01) 1.03 1.06 97 1.03 (0.79) 0.79 0.62 98
ˇ2 1 0.99 (0.85) 0.94 0.89 98 1.01 (0.63) 0.81 0.66 97
1 0.2 0.21 (0.35) 0.35 0.13 94 0.22 (0.24) 0.25 0.06 94
2 0.5 0.58 (0.35) 0.36 0.14 94 0.55 (0.24) 0.24 0.06 94
3 0.1 0.11 (0.06) 0.06 0.004 95 0.10 (0.04) 0.04 0.002 93
ˇ2  ˇ1 0 0.02 (1.45) 1.42 2.01 95 0.02 (1.13) 1.15 1.31 96
MSE, mean square error.
aAverage of the posterior means over 1000 data sets (average of the posterior standard deviations over the 1000
data sets).
bStandard deviation of the posterior means across 1000 data sets.
cCoverage of the 95 percentage highest posterior density interval.
Table II. Percent of times threshold model is chosen over non-threshold model.
Selection criterion n  D 3  D 5  D 7 No threshold
DIC3a 200 75 88 86 8
400 97 100 100 6
LPML 200 75 80 80 50
400 86 93 93 50
DIC, deviance information criterion; LPML, log-pseudo-marginal likelihood.
aIn DIC3, threshold model is selected if its DIC3 is less than the non-threshold model
by more than 3.
regardless of different values of  . The accuracy is further improved when sample size is increased to
n D 400, as evidenced by significantly reduced standard deviations and mean squared error (MSE) given
about 95% coverage probability.
In the last scenario where no threshold is present in ´2, the mean of  is around 5, which is in the
middle of the range ´2 from 0 to 10, but with large standard deviations (ESE  3). The reason is that
 is constrained to be in the range of ´2 in each Gibbs sampling step, thereby leading to an average ´2
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to be the estimate of  , and the standard deviation is increased when n is increased to 400. Furthermore,
the hypothesis of no threshold is strengthened by testing the contrast of ˇ2  ˇ1 (the point estimates are
very close to 0: 0.02 with n D 200 and 0.02 with n D 400). From 1000 experimental replications, the
95% highest posterior density (HPD) intervals of the contrast include 0 for about 95% of the times.
As a rule of thumb, if two models differ in DIC by more than 3, the one with smaller DIC is preferred
as the best fitting [21]. Based on both DIC3 and LPML, threshold models are preferred to the models that
ignore the threshold (called non-threshold model) when a threshold is truly present. As shown in Table II,
when  D 5, 88% (based on DIC3) and 80%(based on LPML) of the time, the threshold model is chosen
over the non-threshold model. In all cases studied, the correct models are chosen more frequently when
n is increased to 400. When there is truly no threshold, DIC3 tends to prefer the simpler non-threshold
model, evidenced by the non-threshold model chosen over the threshold model 92% (100–8%) of the
time. In contrast, LPML seems to have no penalty for more complicated models; half of the time, the
threshold model is chosen although no threshold is present. In addition, using 3 as a threshold for DIC3
comparisons seems to yield reasonable types I and II errors.
Normal priors for ˇ and  are routinely used in the regression models. In this application, we adopted
very vague priors for these parameters (relative to the likelihood) in the aforementioned simulation stud-
ies and the oropharynx cancer example in the next section. However, the posterior distribution of  could
be sensitive to the gamma process prior. This prior consists of an initial estimate of the cumulative base-
line hazard function ƒ0 and a precision c0. In reality, an exponential distribution of ƒ0 is used mostly
for convenience. It is easy to have a prior guess on the average event rate and assume it to be constant
in the study period. Therefore, it is important to evaluate the robustness of the exponential distribution
in the proposed model. For this purpose, we repeated the aforementioned simulation when  D 5 and
generated the baseline hazard function from three Weibull distributions: scenario I (Weibull.0:9; 1:33/),
scenario II (Weibull.1:1; 0:8/), and scenario III (Weibull.1; 1/), where a is a scale parameter and b is a
shape parameter in Weibull.a; b/. In all the three scenarios, the average rate is 1. We then applied the
proposed model using an exponential distribution for ƒ0 with a rate equal to 1 (the same as the true
rate) or 0.1 (much lower than the true rate). We also varied the degree of confidence in the prior guess
by considering c0 D 0:01; 0:1; 5, and 10.
As shown in Table III, the exponential prior (when k0 D 1) works well even when the hazard function
is not exponential, and using the Weibull distribution did not improve the performance even when the
parameters in the Weibull prior are the same as the truth. The independent assumption between the dis-
joint intervals in the posterior inference makes the parametric form of the hazard function less important
and the rate per interval more important. As expected, when  is incorrectly specified (e.g.,  D 0:1), a
large precision, c0, resulted in considerably increased bias, ESE, and MSE.
5. Oropharynx cancer example
We now elaborate on and analyze the data from the motivating example in Section 1. The data were
collected from 220 patients with oropharynx cancer enrolled in the University of Michigan Head and
Neck Cancer Specialized Programs of Research Excellence during the years 2003 to 2008. Of the 220
patients, 84 died, 55 of whom died from oral cavity cancer, and the remaining 136 were alive at the
end of follow-up. Of the 220 patients, 36 are female and 184 are male; 11 patients had stage II, 37
had stage III, and 172 had stage IV. The mean age is 58 years (range from 22 to 86 years). A K-M
survival curve (Figure 1) for the whole data set has a level region beyond about 60 months, which
may indicate the appropriateness of a cure model. Patients who survive after the last observed survival
time are considered as cured in our mixture model, which effectively eliminates the problem of lack of
identifiability [25].
The priors for ˇ and  are the same as in the simulation studies. They are very vague relative to the
likelihood. To construct a reasonable prior for the baseline hazard, we fit our proposed model using data
from all head and neck cancer patients excluding the oropharynx cancer patients (n D 256), and we
obtained an estimate of 0.1 for the baseline hazard rate of  assuming that the hazard is constant over
time (a similar strategy was used in Ibrahim et al. [26] to construct a prior for the baseline hazard rate).
We then set c0 to be 0.01 to reflect the uncertainty of our estimate of the hazard rate in the oropharynx
population. The prior for the other parameters is the same as in the simulation studies. With a burn-in
of 20,000 iterations, an additional 20,000 iterations were used for inference. We observed that the chain
mixes well, and the results are robust to different choices of the initial values.
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Table III. Performance of  under different gamma process priors.
Priora
Scenario  k0 c0 Mean (bias)b ESEc MSE CPd
I 0:1 1 0:01 4.97 (0.45) 0.90 0.48 95
1 1 0:01 5.00 (0.04) 0.90 0.49 95
0:1 1 0:1 4.99 (0.11) 0.91 0.47 95
1 1 0:1 5.00 (.001) 0.90 0.50 95
0:1 1 5 4.93 (1.47) 1.08 0.50 97
1 1 5 5.02 (0.36) 0.90 0.47 96
0:1 1 10 4.84 (3.16) 1.13 0.59 96
1 1 10 5.00 (.008) 0.91 0.44 96
0:9 1:33 0.1 4.99 (0.12) 0.88 0.46 96
0:9 1:33 5 5.00 (0.09) 0.79 0.52 94
II 0:1 1 0:01 4.99 (0.11) 1.06 0.55 96
1 1 0:01 5.00 (0.04) 1.05 0.54 96
0:1 1 0:1 1.99 (0.23) 1.07 0.50 96
1 1 0:1 5.00 (0.09) 1.05 0.52 96
0:1 1 5 4.89 (2.20) 1.15 0.54 97
1 1 5 5.02 (0.34) 0.98 0.53 96
0:1 1 10 4.83 (3.42) 1.17 0.69 97
1 1 10 5.01 (0.26) 0.95 0.50 95
1:1 0:8 0.1 4.99 (0.24) 1.05 0.51 96
1:1 0:8 5 5.01 (0.17) 1.05 0.58 97
III 0:1 1 0:01 4.99 (0.21) 0.97 0.49 96
1 1 0:01 5.00 (0.08) 0.97 0.54 96
0:1 1 0:1 5.01 (0.07) 0.98 0.52 95
1 1 0:1 4.99 (0.23) 0.98 0.51 95
0:1 1 5 4.92 (1.75) 1.11 0.53 97
1 1 5 5.01 (0.28) 0.93 0.53 95
0:1 1 10 4.82 (3.43) 1.14 0.60 97
1 1 10 5.00 (.007) 0.92 0.50 95
MSE, mean squared error.
aScenarios denoted by  are those when the prior matches the true distribution.
bAverage of the posterior means over 1000 data sets (bias is defined as j.Mean  5/=5  100j).
cAverage of the posterior standard deviation over 1000 data sets.
dCoverage of the 95 percentage highest posterior density interval.
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Figure 1. Kaplan–Meier disease-specific survival plots for all ages.
As shown in Table IV, there is no difference in disease-specific survival between women and men
when age is not considered (see model 1). However, a significant gender effect is revealed when the
analysis is conditional on age. Model 2 indicates an interaction between gender and age in the latency,
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Table IV. Parameter estimates and performance statistics for the oropharynx cancer example.
Covariate Mean SE 95% HPD
Model 1: Mixture cure model
Latency Sex (F vs M) 0.16 0.54 (1.23, 0.85)
Age 0.003 0.02 (0.04, 0.03)
Stage 0.13 0.42 (0.92, 0.74)
Incidence Sex (F vs M) 0.28 0.56 (0.83, 1.45)
Age 0.008 0.02 (0.04, 0.03)
Stage 0.34 0.49 (1.24, 0.68)
Model 2: Mixture cure model with an interaction
Latency Sex (F vs M) 0.002 0.56 (1.02, 1.08)
Age 0.001 0.02 (0.03, 0.03)
Stage 0.13 0.44 (0.71, 1.03)
Sex  Age 0.18 0.05 (0.28, 0.09)
Incidence Sex (F vs M) 0.28 0.52 (0.78, 1.30)
Age 0.01 0.02 (0.04, 0.03)
Stage 0.20 0.45 (1.10, 0.66)
Model 3: Mixture cure model with a threshold
Latency Threshold ( ) 65 7 (51, 75)
Sex (age 6  ) (F vs M) 1.50 0.73 (0.04, 2.91)
Sex (age >  ) (F vs M) 2.92 1.38 (5.45, 0.17)
Age 0.001 0.02 (0.03, 0.04)
Stage 0.03 0.45 (0.78, 0.95)
Incidence Sex (F vs M) 0.35 0.52 (0.61, 1.36)
Age 0.008 0.02 (0.04, 0.02)
Stage 0.26 0.44 (1.04, 0.67)
SE, standard error; HPD, highest posterior density.
Table V. Model comparisons.
Models DIC3 (pD) LPML
1 795 (66) 470
2 780 (65) 464
3 783 (66) 466
4 788 (66) 467
5 794 (66) 475
6 781 (66) 464
7 783 (66) 465
DIC, deviance information criterion; LPML, log-
pseudo-marginal likelihood.
and model 3 provides an estimate of a threshold in age such that the gender effect changes after the
threshold. Both DIC and LPML favor models that considered the interaction between age and gender
(Table V). Model 1 has significantly higher DIC and lower LPML than other models. Although model
2 has slightly lower DIC than model 3, the two models are considered to fit the data equally well using
the cutoff of three (the choice of three is good in terms of the desired error rates as shown in the afore-
mentioned simulation studies). The slightly higher LPML in model 2 seems to suggest that fitting the
interaction using the continuous age is better than dichotomizing the age; however, a threshold can be
important in clinical practice as emphasized in Section 1. We are willing to trade a little bit of goodness
of fit of the model for a useful application, and this slight sacrifice is negligible in terms of the pseudo-
Bayes factor for comparing model 2 to model 3, defined as PBF23 D exp.LPML2  LPML3/ D 2:7
[27]. In model 3, the point estimate of  is 65, and men have significantly better prognosis in disease-
specific survival for patients younger than  , and women have significantly better prognosis for patients
older than  (95% HPD interval of the contrast ˇ2  ˇ1 is (1.8, 7.4)). Figure 2 presents the switched
gender effect conditional on the point estimate of the threshold. This significant gender effect will not
be detected when a threshold model is not considered.
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Figure 2. (a) Kaplan–Meier disease-specific survival plots for patients 65 years old or younger (point estimate
of ). (b) Kaplan–Meier disease-specific survival plots for patients older than 65 years.
To validate the presence of a cure fraction, we fitted the data using a regular Cox regression model
with a threshold in age (called model 4), namely a model 3 without the incidence part. A considerably
increased DIC3 of 788, compared to model 3, indicates that the model with a cure fraction is a good
choice. Without the cure fraction, we did not find a clear threshold in age, as evidenced by a large 95%
HPD interval in  ranging from 28 to 85. The gender effect before and after the  is estimated with a
large variance caused by the large uncertainty in estimating  (results not shown).
In this application, we also considered three other models to evaluate the potential threshold of age
in incidence. Model 5 assumes a threshold in the incidence rather than in the latency. A large DIC of
794 and a large 95% HPD interval of  from ages 27 to 86 years supports the absence of a threshold
in age in the incidence. Model 6 adds an additional interaction of age and gender in incidence to model
2. The interaction in the incidence is not significant, the 95% HPD interval of the interaction is (0.05,
0.13), and both the DIC and LPML are very close to model 2. Based on model 3, model 7 updates the
parameters in the logistic regression given each realization of the threshold in latency. That is, model
7 assumes the same threshold in latency exists in incidence. Again, the gender effect is similar before
and after the threshold in incidence, and both the DIC and LPML are very close to model 3. The two
stable plateaus in the K-M curves are not statistically different in Figure 2(a, b), which seems to further
confirm that no threshold is present in the incidence. The results for models 6 and 7 were not shown as
the parameter estimations are similar to models 2 and 3, respectively.
6. Discussion
In this paper, we develop a Bayesian approach to estimate a Cox proportional hazards cure model and
extend the Cox model to allow a threshold in the regression coefficient. Personalized therapy is the future
of oncology drug development. Dichotomizing a continuous biomarker is a common practice in clinical
research because it facilitates a decision to be made about which therapy to give and is easy to include
in protocols. Compared to other methods in finding the optimal threshold for categorizing continuous
variable by maximizing some likelihood function or test statistic [28,29], our method has the advantages
of (i) taking into account the sampling variation in estimating the threshold, as well as other parameters
in the model that depend on the variable threshold; (ii) obtaining a distribution of the threshold; (iii)
adjusting for other prognostic variables when estimating the threshold; (iv) directly testing the absence
or presence of a threshold; and (v) evaluating the assumption of a sudden jump of a covariate at the
threshold by comparing to a model with an interaction term using model selection criterions.
The introduction of the latent Bernoulli cure indicators greatly facilitates the MCMC algorithm. Given
the indicators, the latency and incidence can be evaluated separately using standard methods, and the
threshold detection problem reverts to a problem in the Cox model. Chen et al. [30] noted that Bayesian
inference for a mixture cure model requires proper priors to avoid the possibility of improper posterior
distributions. We avoid this issue by using very mildly informative but proper priors.
In this study, we are interested in a threshold in the latency. We found that the MCMC algorithm had
high autocorrelation and slow convergence when we tried to estimate a threshold in both latency and
incidence for the same covariate. If the threshold in the latency model is your primary interest, you can
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simply update the parameters in the logistic regression given each realization of the threshold in latency,
as describe in model 5 in the oropharynx cancer example.
In this paper, we have used a mixture cure model in which covariate effects are separately considered
for incidence and latency, and thus the threshold effect on covariates can also be considered separately
on incidence and latency. We believe that a covariate that is important for long-term incidence may not
be important for latency and vice versa. We did not consider this threshold detection problem in the
bounded cumulative hazard cure model [26,30–33]. But it would be a nice alternative cure model if you
believe that a covariate is equally important in both latency and incidence.
The parameter estimates (point or interval estimates) are calculated using the MCMC iterations from
the proposed model rather than based on asymptotic approximation as in frequentist approaches. More-
over, estimates of the contrast ˇ2  ˇ1 can be calculated easily to evaluate the existence of a threshold.
This ad hoc way of testing the presence or absence of a threshold combined with the model selection
criterions works well in our study.
In this application, we estimate a threshold in a continuous variable such that the effect of a
dichotomized variable changes before and after the threshold. With some modification of the design
matrix X , this method can be used to estimate a threshold in a covariate as described in Jensen and Lutke-
bohmert [4], where the covariate effect has a piecewise linear functional form. Extensions to multiple
threshold detection using reversible jump MCMC [34] will be the subject of future research.
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